1. Rumman, Mohammad, Dhawan, Jyotsna. 2022. PTPRU, a quiescence-induced receptor tyrosine phosphatase negatively regulates osteogenic differentiation of human mesenchymal stem cells. In Biochemical and biophysical research communications, 636, 41-49. doi:10.1016/j.bbrc.2022.10.062. https://pubmed.ncbi.nlm.nih.gov/36332481/
2. Gu, Jiayi, Zhang, Zhiqi, Lang, Tingyuan, Han, Kun, Qiu, Jiangfeng. 2019. PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway. In OncoTargets and therapy, 12, 8095-8104. doi:10.2147/OTT.S218125. https://pubmed.ncbi.nlm.nih.gov/31632062/
3. Grad, Meitar, Nir, Ariel, Levy, Gilad, Assaf, Yaniv, Barak, Boaz. 2022. Altered White Matter and microRNA Expression in a Murine Model Related to Williams Syndrome Suggests That miR-34b/c Affects Brain Development via Ptpru and Dcx Modulation. In Cells, 11, . doi:10.3390/cells11010158. https://pubmed.ncbi.nlm.nih.gov/35011720/